Publicaciones en colaboración con investigadores/as de Universidad de Cantabria (11)

2024

  1. Dysregulated FOXO1 activity drives skeletal muscle intrinsic dysfunction in amyotrophic lateral sclerosis

    Acta Neuropathologica, Vol. 148, Núm. 1

2021

  1. Virtual meeting, real and sound science: Report of the 17th Meeting of the Spanish Society for Developmental Biology (SEBD-2020)

    International Journal of Developmental Biology, Vol. 52

2018

  1. Selective up-regulation of cannabinoid CB1 receptor coupling to Go-proteins in suicide victims with mood disorders

    Biochemical Pharmacology, Vol. 157, pp. 258-265

2014

  1. A screen for transcription factor targets of glycogen synthase kinase-3 highlights an inverse correlation of NFκB and androgen receptor signaling in prostate cancer

    Oncotarget, Vol. 5, Núm. 18, pp. 8173-8187

2010

  1. Long-term fluoxetine treatment modulates cannabinoid type 1 receptor-mediated inhibition of adenylyl cyclase in the rat prefrontal cortex through 5-hydroxytryptamine1A receptor-dependent mechanisms

    Molecular Pharmacology, Vol. 77, Núm. 3, pp. 424-434

2007

  1. Both increases in immature dentate neuron number and decreases of immobility time in the forced swim test occurred in parallel after environmental enrichment of mice

    Neuroscience, Vol. 147, Núm. 3, pp. 631-638

  2. CB1 knockout mice display impaired functionality of 5-HT 1A and 5-HT2A/C receptors

    Journal of Neurochemistry, Vol. 103, Núm. 5, pp. 2111-2120

2004

  1. A single in-vivo exposure to Δ9THC blocks endocannabinoid-mediated synaptic plasticity

    Nature Neuroscience, Vol. 7, Núm. 6, pp. 585-586

  2. Influence of age, postmortem delay and freezing storage period on cannabinoid receptor density and functionality in human brain

    Neuropharmacology, Vol. 46, Núm. 5, pp. 716-726

2003

  1. Ontogenetic development of cannabinoid receptor expression and signal transduction functionality in the human brain

    European Journal of Neuroscience, Vol. 17, Núm. 9, pp. 1747-1754

2002

  1. Cannabinoid receptor antagonism and inverse agonism in response to SR141716A on cAMP production in human and rat brain

    European Journal of Pharmacology, Vol. 443, Núm. 1-3, pp. 43-46